|
Home » Resources » Research Articles » Neurofeedback Treatment for Attention-Deficit/ Hyperactivity Disorder in Children: A Comparison With Methylphenidate
Neurofeedback Treatment for Attention-Deficit/ Hyperactivity Disorder in Children: A Comparison With Methylphenidate
Applied Psychophysiology and Biofeedback, Vol. 28,
No. 1, March 2003 ( C?2003) Thomas Fuchs, Niels Birbaumer, Werner Lutzenberger,
John H. Gruzelier, and Jochen Kaiser
Clinical trials have suggested that neurofeedback may
be efficient in treating attention-deficit / hyperactivity disorder
(ADHD). We compared the effects of a 3-month electroenecephalographic
feedback program providing reinforcement contingent on the production
of cortical sensorimotor rhythm (12–15 Hz) and beta1 activity
(15–18 Hz) with stimulant medication. Participants were N = 34
children aged 8–12 years, 22 of which were assigned to the neurofeedback
group and 12 to the methylphenidate group according to their parents’
preference. Both neurofeedback and methylphenidate were associated with
improvements on all subscales of the Test of Variables of Attention,
and on the speed and accuracy measures of the d2 Attention Endurance
Test. Furthermore, behaviors related to the disorder were rated as significantly
reduced in both groups by both teachers and parents on the IOWA-Conners
Behavior Rating Scale. These findings suggest that neurofeedback was
efficient in improving some of the behavioral concomitants of ADHD in
children whose parents favored a non pharmacological treatment.
Introduction
Attention-de?cit /hyperactivity disorder (ADHD) is a behavioral disorder
characterized by inattentiveness, impulsivity, and hyperactivity, affecting
3–5% of school-aged children (The MTA Cooperative Group, 1999).
Current etiological theories have linked ADHD to abnormalities in dopaminergic
and, possibly, noradrenergic cortico-subcortical networks relevant for
executive functions and the regulation of behavioral responses.
To read more of this article visit The
National Library of Medicine
|